Literature DB >> 30569188

Pitfalls in Ga-68-PSMA-PET/CT: incidental finding of parathyroid adenoma.

Christian H Pfob1, Ilham Karimov2, Moritz Jesinghaus3,4, Alexander Novotny5, Wolfgang A Weber2, Matthias Eiber2, Benedikt Feuerecker2,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30569188     DOI： 10.1007/s00259-018-4239-1

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  5 in total

1.  First evidence of PSMA expression in differentiated thyroid cancer using [⁶⁸Ga]PSMA-HBED-CC PET/CT.

Authors:  Frederik A Verburg; Thomas Krohn; Alexander Heinzel; Felix M Mottaghy; Florian F Behrendt
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-04-28       Impact factor: 9.236

2.  Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium.

Authors:  H Liu; P Moy; S Kim; Y Xia; A Rajasekaran; V Navarro; B Knudsen; N H Bander
Journal:  Cancer Res       Date:  1997-09-01       Impact factor: 12.701

3.  Prostate-specific membrane antigen expression in normal and malignant human tissues.

Authors:  D A Silver; I Pellicer; W R Fair; W D Heston; C Cordon-Cardo
Journal:  Clin Cancer Res       Date:  1997-01       Impact factor: 12.531

4.  68Ga-PSMA-HBED-CC PET for Differential Diagnosis of Suggestive Lung Lesions in Patients with Prostate Cancer.

Authors:  Thomas Pyka; Gregor Weirich; Ingo Einspieler; Tobias Maurer; Jörg Theisen; Georgios Hatzichristodoulou; Kristina Schwamborn; Markus Schwaiger; Matthias Eiber
Journal:  J Nucl Med       Date:  2015-11-19       Impact factor: 10.057

5.  Expression of prostate-specific membrane antigen in normal and malignant human tissues.

Authors:  Yoshihisa Kinoshita; Katsuyuki Kuratsukuri; Steve Landas; Katsumi Imaida; Peter M Rovito; Ching Y Wang; Gabriel P Haas
Journal:  World J Surg       Date:  2006-04       Impact factor: 3.282
  5 in total
  4 in total

1.  Cancers and Benign Processes on 68 Ga PSMA PET-CT Imaging Other than Prostate Cancer.

Authors:  Pinar Pelin Ozcan; Mustafa Serdengectı; Zehra Pinar Koc; Yüksel Balcı; Mesut Tek; Murat Bozlu; Erdem Akbay; Vehbi Erçolak
Journal:  World J Nucl Med       Date:  2022-07-05

2.  Pitfalls in PSMA imaging: [18F]rhPSMA-7-PET/CT reveals presence of chrondrosarcoma.

Authors:  B Feuerecker; C Mogler; K Wörtler; C Knebel; M Eiber; M Krönke
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-02-25       Impact factor: 9.236

Review 3.  Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings.

Authors:  Felipe de Galiza Barbosa; Marcelo Araujo Queiroz; Rafael Fernandes Nunes; Larissa Bastos Costa; Elaine Caroline Zaniboni; José Flavio Gomes Marin; Giovanni Guido Cerri; Carlos Alberto Buchpiguel
Journal:  Cancer Imaging       Date:  2020-03-14       Impact factor: 3.909

Review 4.  Current status of radioligand therapy and positron-emission tomography with prostate-specific membrane antigen.

Authors:  Masayuki Inubushi; Hiroyuki Miura; Ichiei Kuji; Kimiteru Ito; Ryogo Minamimoto
Journal:  Ann Nucl Med       Date:  2020-11-11       Impact factor: 2.668
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.